Taylor, P., Keystone, E., Van der Heijde, D., Weinblatt, M., del Carmen Morales, L., Reyes Gonzaga, J., . . . Tanaka, Y. (2017). Baricitinib versus placebo or adalimumab in rheumatoid arthritis. Massachusetts Medical Society.
Čikaški stil citiranja (17. izdanje)Taylor, P., et al. Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis. Massachusetts Medical Society, 2017.
MLA način citiranja (9. izdanje)Taylor, P., et al. Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis. Massachusetts Medical Society, 2017.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.